150 related articles for article (PubMed ID: 37500075)
1. The E3 ligase DTX2 inhibits RUNX1 function by binding its C terminus and prevents the growth of RUNX1-dependent leukemia cells.
Yonezawa T; Takahashi H; Hao Y; Furukawa C; Tsuchiya A; Zhang W; Fukushima T; Fukuyama T; Sawasaki T; Kitamura T; Goyama S
FEBS J; 2023 Nov; 290(21):5141-5157. PubMed ID: 37500075
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1.
Yonezawa T; Takahashi H; Shikata S; Liu X; Tamura M; Asada S; Fukushima T; Fukuyama T; Tanaka Y; Sawasaki T; Kitamura T; Goyama S
J Biol Chem; 2017 Jul; 292(30):12528-12541. PubMed ID: 28536267
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia with t(7;21)(q11.2;q22) expresses a novel, reversed-sequence RUNX1-DTX2 chimera.
Maki K; Sasaki K; Sugita F; Nakamura Y; Mitani K
Int J Hematol; 2012 Aug; 96(2):268-73. PubMed ID: 22661044
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin ligase RNF38 promotes RUNX1 ubiquitination and enhances RUNX1-mediated suppression of erythroid transcription program.
Yonezawa T; Takahashi H; Shikata S; Sawasaki T; Kitamura T; Goyama S
Biochem Biophys Res Commun; 2018 Nov; 505(3):905-909. PubMed ID: 30309654
[TBL] [Abstract][Full Text] [Related]
5. CHIP functions an E3 ubiquitin ligase of Runx1.
Shang Y; Zhao X; Xu X; Xin H; Li X; Zhai Y; He D; Jia B; Chen W; Chang Z
Biochem Biophys Res Commun; 2009 Aug; 386(1):242-6. PubMed ID: 19524548
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation.
Jin YH; Jeon EJ; Li QL; Lee YH; Choi JK; Kim WJ; Lee KY; Bae SC
J Biol Chem; 2004 Jul; 279(28):29409-17. PubMed ID: 15138260
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
9. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region.
Fowler M; Borazanci E; McGhee L; Pylant SW; Williams BJ; Glass J; Davis JN; Meyers S
J Cell Biochem; 2006 Jan; 97(1):1-17. PubMed ID: 16237704
[TBL] [Abstract][Full Text] [Related]
10. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
[TBL] [Abstract][Full Text] [Related]
11. Transcription factors Runx1 to 3 are expressed in the lacrimal gland epithelium and are involved in regulation of gland morphogenesis and regeneration.
Voronov D; Gromova A; Liu D; Zoukhri D; Medvinsky A; Meech R; Makarenkova HP
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3115-25. PubMed ID: 23532528
[TBL] [Abstract][Full Text] [Related]
12. [Epigenetic mechanism of RUNX1 in pathogenesis of leukemia].
Zhang H; Zheng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):525-30. PubMed ID: 20416203
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
Matsumura T; Nakamura-Ishizu A; Muddineni SSNA; Tan DQ; Wang CQ; Tokunaga K; Tirado-Magallanes R; Sian S; Benoukraf T; Okuda T; Asou N; Matsuoka M; Osato M; Suda T
Blood; 2020 Oct; 136(17):1919-1932. PubMed ID: 32573733
[TBL] [Abstract][Full Text] [Related]
14. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
15. Runx1 Phosphorylation by Src Increases Trans-activation via Augmented Stability, Reduced Histone Deacetylase (HDAC) Binding, and Increased DNA Affinity, and Activated Runx1 Favors Granulopoiesis.
Leong WY; Guo H; Ma O; Huang H; Cantor AB; Friedman AD
J Biol Chem; 2016 Jan; 291(2):826-36. PubMed ID: 26598521
[TBL] [Abstract][Full Text] [Related]
16. RUNX1 translocations in malignant hemopathies.
De Braekeleer E; Férec C; De Braekeleer M
Anticancer Res; 2009 Apr; 29(4):1031-7. PubMed ID: 19414342
[TBL] [Abstract][Full Text] [Related]
17. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
18. RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.
Koh CP; Wang CQ; Ng CE; Ito Y; Araki M; Tergaonkar V; Huang G; Osato M
Leukemia; 2013 Sep; 27(9):1793-802. PubMed ID: 23817177
[TBL] [Abstract][Full Text] [Related]
19. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
[TBL] [Abstract][Full Text] [Related]
20. RUNX1-RUNX1 homodimerization modulates RUNX1 activity and function.
Li D; Sinha KK; Hay MA; Rinaldi CR; Saunthararajah Y; Nucifora G
J Biol Chem; 2007 May; 282(18):13542-51. PubMed ID: 17355962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]